{
    "root": "8e22600e-a1a2-432c-a47c-b7b99a0b1e46",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "FLUOCINONIDE",
    "value": "20250227",
    "ingredients": [
        {
            "name": "FLUOCINONIDE",
            "code": "2W4A77YPAN"
        },
        {
            "name": "CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)",
            "code": "4Q93RCW27E"
        },
        {
            "name": "EDETATE DISODIUM",
            "code": "7FLD91C86K"
        },
        {
            "name": "PROPYL GALLATE",
            "code": "8D4SNN7V92"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "Fluocinonide Gel USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.",
    "contraindications": "Fluocinonide Gel USP, 0.05% is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition.\n                  Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.\n                  If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.",
    "warningsAndPrecautions": "Fluocinonide Gel USP, 0.05% is supplied in the following:\n                  15 g (NDC 45802-761-15)\n                  30 g (NDC 45802-761-30) and\n                  60 g (NDC 45802-761-60) tubes.\n                  \n                     Store at 20°- 25°C (68°- 77°F) [see USP Controlled Room Temperature]\n                  Manufactured by Padagis®, Yeruham, Israel\n                  www.padagis.com\n                  Rev 08-247D000 RC PH2",
    "adverseReactions": "Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations."
}